COAG - CIK 0002114044
The table below shows Hemab Therapeutics Holdings, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 |
|---|---|---|
| Operating cash flow | -$21.58M | -$13.03M |
| Capital expenditure | $112.00K | $16.00K |
| Investing cash flow | -$15.85M | -$5.99M |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | -$460.00K | -$29.00K |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.